Correction to: Nature Communications https://doi.org/10.1038/s41467-020-19810-w, published online 7 December 2020
There was an error in the original version of this Article. A table describing the patient characteristics and the sample collection was not included in the paper. This table is now included as Supplementary Data 1 and the first sentence of the Results section has been amended to state ‘Between December 2013 and April 2015, 99 patients were screened. Sixty-eight patients were enrolled from 11 study centers (Supplementary Fig. 1, Supplementary Data 1), with 31 patients subsequently excluded due to screening failures’. The PDF and HTML versions of the Article have been updated.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ribas, A., Algazi, A., Ascierto, P.A. et al. Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma. Nat Commun 12, 5022 (2021). https://doi.org/10.1038/s41467-021-25285-0
Published:
Version of record:
DOI: https://doi.org/10.1038/s41467-021-25285-0
